Pragliola Claudio, Hassan Essam, Ismail Huda, Al Otaibi Khalid, Alfonso Juan J, Algarni Khaled D
Catholic University School of Medicine, Rome, Italy; Prince Sultan Cardiac Centre, Riyadh, Saudi Arabia; King Faisal University School of Medicine, Riyadh, Saudi Arabia.
Prince Sultan Cardiac Centre, Riyadh, Saudi Arabia; Tanta University, Tanta, Egypt.
Heart Lung Circ. 2020 Sep;29(9):1405-1411. doi: 10.1016/j.hlc.2019.08.019. Epub 2019 Dec 9.
Paediatric del Nido cardioplegia (DNC) has been tested in selected populations of low-risk adult patients. This study examined its use in an unselected medium-to-high-risk adult population and compared the results with a propensity-matched population that received intermittent warm blood cardioplegia (IWBC).
Data from the last 1,000 consecutive adult patients who underwent a variety of surgical procedures under cardioplegic arrest with the use of IWBC or DNC between 2016 and 2018 were propensity score matched on preoperative clinical and demographic variables. Two (2) main populations were 102 patients who received DNC and another set of matched 102 patients from a total of 1,000 patients who received IWBC, along with a subgroup with an ejection fraction (EF) ≤40% (EFDNC vs EFIWBC). Postoperative outcomes were mortality, peak troponin T, postoperative EF%, and aortic cross-clamp time.
There were no preoperative differences amongst the groups in the main cohort (Euroscore II: DNC 4.1±8, IWBC 4.0±7; EF%: DNC 47±10, IWBC 47±11) and in the subgroup (EF%: EFDNC 32±6%, EFIWBC 32±6%; p=0.45). There were also no differences in three of the outcomes. A significant postoperative improvement was noticed in the EF% in the DNC (32±6% 95% CI 29-34 to 39±12 95% CI 34-44; p=0.001) in the EFDNC group.
This initial experience of del Nido cardioplegia proved to be effective in a variety of challenging pathologies in adult populations.
小儿德尔尼多停搏液(DNC)已在部分低风险成年患者群体中进行了测试。本研究考察了其在未经筛选的中高风险成年人群中的应用,并将结果与接受间歇性温血停搏液(IWBC)的倾向匹配人群进行了比较。
对2016年至2018年间连续1000例在停搏液灌注下接受各种外科手术的成年患者的数据,根据术前临床和人口统计学变量进行倾向评分匹配。两个主要群体分别为102例接受DNC的患者,以及从总共1000例接受IWBC的患者中匹配的另一组102例患者,还有一个射血分数(EF)≤40%的亚组(EFDNC与EFIWBC)。术后结局指标为死亡率、肌钙蛋白T峰值、术后EF%和主动脉阻断时间。
主要队列中的各组之间术前无差异(欧洲心脏手术风险评估系统II评分:DNC组4.1±8,IWBC组4.0±7;EF%:DNC组47±10,IWBC组47±11),亚组中也无差异(EF%:EFDNC组32±6%,EFIWBC组32±6%;p = 0.45)。三项结局指标也无差异。在EFDNC组中,DNC组的EF%术后有显著改善(32±6% 95%CI 29 - 34至39±12 95%CI 34 - 44;p = 0.001)。
德尔尼多停搏液的这一初步经验证明,其在成年人群体的各种具有挑战性的病情中是有效的。